This private member's bill broadens the Act's definition of “medical aid,” explicitly including any health care service, product or device needed to cure, prevent deterioration, maintain function, relieve pain or preserve quality of life, and it authorizes reasonable expenses such as transportation. It replaces discretionary language in the Act with mandatory obligations: the Workers' Compensation Board (WCB) must provide medical aid that is necessary and must give meaningful consideration to treating clinicians' recommendations.
The bill also creates new procedural protections. The Board cannot deny or stop previously approved continuing care unless denial is medically warranted, must provide written reasons supported by a sworn medical statement, give reasonable notice, and — where cessation risks significant deterioration or serious harm — must continue treatment until appeal periods expire.
It adds a dignity standard to decision-making and requires expedited handling of medical-aid disputes involving severe pain or risk of deterioration. These changes reallocate evidentiary burdens and will affect WCB workflows, medical reviewers, appeals bodies and employers who underwrite compensation costs.
At a Glance
What It Does
The bill expands the statutory definition of medical aid, requires the WCB to provide medical aid deemed necessary, and obliges the Board to give meaningful consideration to treating clinicians' recommendations. It bars denials or discontinuances unless medically warranted, mandates written rationales accompanied by a sworn medical statement, requires notice, and triggers continued funding where there is a reasonable possibility of serious harm until appeal windows close.
Who It Affects
Directly affected parties include the Workers' Compensation Board of Nova Scotia, treating physicians and other health professionals, injured workers with ongoing medical needs, the Appeals Tribunal and Medical Review Commission, and employers/insurers who fund the system. Legal representatives and advocacy organizations will see changes to disclosure and evidentiary practices.
Why It Matters
The bill converts discretionary grant-making into enforceable duties, elevates the role of treating clinicians in adjudication, and builds formal procedural protections for continuity of care. For practitioners and compliance officers, this signals likely increases in front-line medical claims, new documentation and evidence requirements, and a potential rise in expedited appeals.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill rewrites the Act’s core definition of “medical aid” so it covers a wide array of health services, devices and products when they are reasonably required because of a compensable injury. That expansion expressly includes reasonable out-of-pocket expenses the Board has authorized, such as transportation costs.
In practice this broadens the menu of treatments and supports that workers can propose for Board funding and requires the Board to account for non-clinical costs tied to access.
The statutory duty in Section 102 has been reframed from permissive to mandatory: where medical aid is necessary, the Board must provide it. Complementing that, the bill requires the Board to give meaningful consideration to recommendations from the treating physician or other health professionals; it cannot simply ignore the treating team's view.
Where the Board intends to deny or stop continuing or previously approved care, it must not do so unless medical evidence shows the change is warranted, and it must supply a written rationale accompanied by a sworn or affirmed statement from a relevant medical professional supporting the decision.Procedurally, the bill imposes notice requirements before discontinuance, and it requires the Board to weigh the medical consequences of stopping treatment. If discontinuing care could reasonably lead to significant deterioration, severe pain, withdrawal or other foreseeable harm, the Board must keep funding the care until appeal periods have elapsed.
The reasons the Board provides when it reduces or stops medical aid must detail the treatment requested, the medical evidence considered (including copies of reports), the statutory or guideline authority relied on, why any treating clinician's recommendation was rejected, and alternatives the Board can fund — plus contact information to help the worker pursue those alternatives.Finally, the bill adds a dignity standard to Section 104, obliging decision-makers to consider the worker’s dignity and medical needs. It also directs the Board, adjudicators and appellate bodies to expedite matters where a worker faces significant deterioration or severe pain and allows those bodies to vary statutory or procedural timeframes to speed decisions without prejudicing justice.
The combined effect is legalizing a faster, more worker-centred process for medical disputes while embedding new evidentiary and administrative burdens into the system.
The Five Things You Need to Know
The statutory definition of “medical aid” is broadened to include any health care service, product or device needed to cure, prevent deterioration, maintain function, relieve pain or preserve quality of life, and to include authorized reasonable expenses such as transportation.
Section 102(1) changes the Board’s role from permissive to mandatory by substituting 'shall' for 'may' and requiring provision of medical aid 'that is' necessary.
The Board must give 'meaningful consideration' to recommendations from the worker’s treating physician or other medical professionals when making medical-aid decisions (new s.102A).
Before denying or discontinuing continuing or previously approved care, the Board must provide written reasons and a sworn or affirmed statement from a relevant medical professional that the denial or discontinuance is medically warranted; it must also give reasonable notice and consider medical consequences (new s.102B–102C).
Where stopping treatment creates a reasonable possibility of significant deterioration, severe pain, withdrawal or other foreseeable harm, the Board must continue funding the treatment until applicable appeal periods have expired, and adjudicative bodies must expedite cases involving such risks (new s.206A).
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Broadened, access-focused definition of 'medical aid'
This clause replaces the old definition with a much broader one that expressly covers services, products and devices tied to cure, function, pain management and quality of life, and it authorizes reimbursement for reasonable expenses such as transportation. Practically, this expands what claimants can submit for funding and forces the Board to evaluate non-traditional supports (assistive devices, community-based services, travel) under the Act’s entitlement rules.
From discretion to duty — ‘may’ becomes ‘shall’
By changing modal language from 'may' to 'shall' and tightening the eligibility phrasing, the bill converts an administrative discretion into a statutory duty to provide necessary medical aid. That shift raises the legal stakes for Board decisions, alters the standard administrators must apply, and could affect judicial review by narrowing the Board’s scope to justify refusals.
Treating clinicians privileged; disclosure and sworn medical support required for denials
Section 102A forces the Board to give meaningful weight to treating clinicians' recommendations. Sections 102B–102C set out procedural safeguards: denials or discontinuances must be medically warranted, require reasonable notice, and must be accompanied by a written rationale plus a sworn or affirmed statement from a relevant medical professional. The Board must also disclose the medical evidence it relied on, explain rejected treating-clinician recommendations, and list alternatives and contact points. These rules change evidence management, increase disclosure, and formalize the role of medical attestations in administrative records.
Dignity and medical needs as express decision factors
The amendment requires the Board to consider the worker’s dignity and medical needs when making decisions. While short, this clause introduces a qualitative standard that adjudicators must factor into assessments of reasonableness and proportionality — an interpretive hook for workers and tribunals to weigh non-medical impacts of coverage decisions (privacy, autonomy, functional dignity).
Mandated expedited handling and flexible timing for urgent medical disputes
This section directs the Board, hearing officers, the Appeals Tribunal, the Medical Review Commission and the Court of Appeal to expedite matters where a worker faces significant deterioration, severe pain or other serious harm, and it authorizes varying statutory, regulatory or court timeframes to facilitate quick resolution without prejudicing justice. Implementation will require triage criteria, procedural rules for expedited streams, and resourcing to meet compressed timelines.
This bill is one of many.
Codify tracks hundreds of bills on this topic across all five countries.
Explore this topic in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Injured workers with ongoing or complex medical needs — They gain broader eligible treatments, mandated continuity of care during appeal windows when harm is likely, clearer reasons for denials, and an explicit dignity standard to support claims for non-clinical needs.
- Treating physicians and allied health professionals — Their clinical recommendations must receive meaningful consideration, increasing the influence of front-line clinicians on funding decisions and reducing the likelihood that treating-team advice is disregarded without explanation.
- Worker advocates and legal representatives — The bill requires fuller disclosure of the Board’s medical evidence and rationale, making it easier to prepare appeals and challenge denials on procedural or evidentiary grounds.
Who Bears the Cost
- Workers' Compensation Board of Nova Scotia — The Board must expand documentation, obtain or manage sworn medical attestations, maintain disclosure packages, and operate expedited processes, increasing administrative and clinical-review costs.
- Employers and employer-funded insurers — Broader entitlements, mandated continuations during appeals and faster adjudication could translate into higher short-term claims costs and upward pressure on premium calculations.
- Medical reviewers and external experts retained by the Board — The new sworn-statement requirement and increased evidentiary demands will push the Board to engage more independent medical assessments and potentially pay for sworn opinions, increasing operational expenditures.
Key Issues
The Core Tension
The central dilemma is between guaranteeing prompt, dignified continuity of medically necessary care by deferring to treating clinicians and protecting the system’s integrity and fiscal sustainability through independent review: the bill tilts toward patient-centred access and procedural safeguards, but that tilt raises questions about who decides what care is 'medically warranted', how to standardize expedited procedures, and how to absorb the likely administrative and financial consequences.
The bill raises several implementation questions that could create friction between the goal of continuity of care and the need for objective, sustainable adjudication. Requiring a sworn or affirmed medical statement to justify denials shifts the evidentiary dynamic: who provides that statement (the Board’s own reviewer, an independent expert, or the treating clinician) will matter for perceived impartiality and cost.
The Act does not specify qualification criteria for the 'relevant medical professional' whose sworn statement is needed, leaving room for dispute and potential litigation about adequacy of the supporting opinion.
The 'reasonable possibility' threshold for continuing care during appeals and language like 'significant deterioration' or 'severe pain' are intentionally flexible but imprecise. That vagueness helps protect borderline cases but invites inconsistent application and increased appellate litigation to define terms.
Expedited pathways will speed some decisions, yet they risk squeezing investigative time and straining tribunal resources; the power to vary timeframes is useful but depends on guidance and resourcing. Finally, broadening the definition of medical aid and authorizing transportation costs increases entitlement scope and budgetary exposure without built-in fiscal offsets or clear prioritization rules, setting up a classic tensions between access to care and system sustainability.
There's more to this law than the bill.
Codify Laws traces every connection across the legislative lifecycle.